Jianbin Mao, PhD

Director of Global Value and Access
Acceleron Pharma

Disclosure: Merck & Co. (Employee, Shareholder)

Presentation(s):

• 71 - Increasing Trends in Multimorbidity and Polypharmacy Over a 5-Year Period in People Living with HIV in the United States

  On Demand